Dave Nirschl
About Dave Nirschl
Dave Nirschl is the Senior Director, IT Business Partner for Nonclinical R&D and Small Molecule Drug Discovery at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical industry.
Title
Dave Nirschl is the Senior Director, IT Business Partner, Nonclinical R&D and Small Molecule Drug Discovery at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Dave Nirschl currently serves as the Senior Director, IT Business Partner, Nonclinical R&D and Small Molecule Drug Discovery. In this role, he is responsible for partnering with nonclinical R&D and small molecule drug discovery teams to align IT initiatives with business objectives, ensuring that technology solutions effectively support research and development goals.
Career at Bristol Myers Squibb
Dave Nirschl has held several key roles at Bristol Myers Squibb over his career. From 2020 to 2021, he was the Senior Director, IT Business Partner, Small Molecule Drug Discovery in Princeton, New Jersey. Earlier, he worked as Director, Head Business Partner, Medical Affairs IT from 2019 to 2020 and Director, Head Business Partner, Discovery Chemistry IT from 2016 to 2019. He started his career at the company as a Senior Principal Scientist, a position he held from 2000 to 2015.
Education and Expertise
Dave Nirschl earned his PhD in Chemistry from The Scripps Research Institute, completing his studies from 1994 to 2000. He also holds a BS in Chemistry from the University of Illinois at Urbana-Champaign, obtained between 1990 and 1994. His educational background in chemistry laid the foundation for his extensive expertise in the pharmaceutical industry.
Experience in Pharmaceutical Industry
With over 20 years of experience in the pharmaceutical industry, Dave Nirschl has a well-rounded background in both IT and R&D roles. His career trajectory from a scientific role to IT leadership within the same company highlights his versatility and adaptability. His expertise spans nonclinical R&D, small molecule drug discovery, and IT business partnerships across various departments, including Medical Affairs and Discovery Chemistry.